RHOSHAN PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, September 13, 2018, a trademark application was filed for RHOSHAN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the RHOSHAN PHARMACEUTICALS trademark a serial number of 88115688. The federal status of this trademark filing is REGISTERED as of Tuesday, December 24, 2019. This trademark is owned by Rho Pharmaceuticals, LLC. The RHOSHAN PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and drug development services; Clinical research and testing services in the fields of pharmaceuticals; Scientific research and development services; Drug discovery services
rhoshan pharmaceuticals

General Information

Serial Number88115688
Word MarkRHOSHAN PHARMACEUTICALS
Filing DateThursday, September 13, 2018
Status700 - REGISTERED
Status DateTuesday, December 24, 2019
Registration Number5945415
Registration DateTuesday, December 24, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical research and drug development services; Clinical research and testing services in the fields of pharmaceuticals; Scientific research and development services; Drug discovery services
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 21, 2018
Primary Code042
First Use Anywhere DateWednesday, October 23, 2019
First Use In Commerce DateWednesday, October 23, 2019

Trademark Owner History

Party NameRho Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSouthampton, PA 18966
Party NameRho Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSouthampton, PA 18966
Party NameRho Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSouthampton, PA 18966

Trademark Events

Event DateEvent Description
Monday, September 17, 2018NEW APPLICATION ENTERED
Friday, September 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 26, 2018ASSIGNED TO EXAMINER
Wednesday, December 26, 2018NON-FINAL ACTION WRITTEN
Wednesday, December 26, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 2, 2019EXAMINERS AMENDMENT -WRITTEN
Saturday, February 2, 2019EXAMINERS AMENDMENT E-MAILED
Saturday, February 2, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, February 2, 2019EXAMINER'S AMENDMENT ENTERED
Saturday, February 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 15, 2019ASSIGNED TO LIE
Wednesday, March 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 1, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, November 14, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 1, 2019USE AMENDMENT FILED
Thursday, November 14, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, November 15, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, November 16, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 24, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 24, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 23, 2025TEAS SECTION 8 & 15 RECEIVED

Related Keywords

pharmaceuticals rhoshan services research development drug scientific discovery clinical pharmaceutical testing